Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 18.13
+1.04 (6.09%)
Sep 12, 2025, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 12.19 billion as of September 12, 2025. Its market cap has increased by 530.76% in one year.
Market Cap
12.19B
Enterprise Value
9.60B
Revenue
678.11M
Ranking
n/a
PE Ratio
74.30
Stock Price
18.13
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 12.19B, an increase of 39.94%. That is a compound annual growth rate of 8.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 12.19B | 323.82% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 300.88B |
| Hansoh Pharmaceutical Group Company | 233.56B |
| JD Health International | 218.82B |
| Innovent Biologics | 170.59B |
| Sino Biopharmaceutical | 157.21B |
| WuXi Biologics | 152.80B |
| CSPC Pharmaceutical Group | 125.08B |
| Akeso | 122.97B |